Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A, et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med. 2012;366:1371–81. https://doi.org/10.1056/NEJMoa1110169.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wachowiak J, Chybicka A, Kowalczyk JR, Wysocki M, Goździk J, Gorczyńska E, Kałwak K, Styczyński J, Drabko K, Pieczonka A. Development and current use of in hematopoietic stem cell transplantation in children and adolescents in Poland: Report of the Polish pediatric study group for hematopoietic stem cell transplantation of the Polish society for pediatric oncology and hematology. Transfus Apher Sci. 2018. https://doi.org/10.1016/j.transci.2018.05.012.
Article
PubMed
Google Scholar
Sung PH, Im C, Hyun SY, Shim KY, Ji L, Kong JH. Unusual isolated extramedullary relapse of acute lymphoblastic leukemia in the breast despite complete donor hematopoietic chimerism after allogeneic hematopoietic stem cell transplantation. Korean J Intern Med. 2018;33:218–20. https://doi.org/10.3904/kjim.2015.089.
Article
PubMed
Google Scholar
Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingebiel T. How and when should we monitor chimerism after allogenic stem cell transplantation? Bone Marrow Transplant. 2005;35:107–19. https://doi.org/10.1038/sj.bmt.1704715.
Article
CAS
PubMed
Google Scholar
Breuer S, Preuner S, Fritsch G, Daxberger H, Koenig M, Poetschger U, et al. Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation. Leukemia. 2012;26:509–19. https://doi.org/10.1038/leu.2011.244.
Article
CAS
PubMed
Google Scholar
Stahl T, Böhme MU, Kröger N, Fehse B. Digital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantation. Exp Hematol. 2015;43:462–8. https://doi.org/10.1016/j.exphem.2015.02.006.
Article
CAS
PubMed
Google Scholar
Chia WC, Khoo TS, Wahid SFSA, Razak NFA, Alauddin H, Sabudin RZAR, Othman A, Hassan R, Hussin NH. Multiplex PCR panel for assessment of chimerism following hematopoietic stem cell transplantation (HSCT). Ann Hematol. 2019;98:1279–91. https://doi.org/10.1007/s00277-019-03626-w.
Article
PubMed
Google Scholar
Lion T. Molecular monitoring after HSCT. Chimerism. In: Apperley J, Carreras E, Gluckman E, Masszi T, editors. The EBMT Handbook, vol. 16.2; 2012. p. 281–7. https://ebmtonline.forumservice.net/media/16_2/tex/content_alt/EBMT_Handbook2012_CHAP16_2.pdf.
Google Scholar
Bader P. Documentation of Engraftment and Chimerism After HSCT. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook Springer, vol. 72. Cham; 2019. p. 539–45. https://doi.org/10.1007/978-3-030-02278-5_20.
Chapter
Google Scholar
Apperley J, Carreras E, Gluckman E, Gratwohl A, Masszi T. Principles of conditioning. In: Apperley J, Carreras E, Gluckman E, Masszi T, editors. Haematopoietic stem cell transplantation. Genoa: Forum Service Editore; 2008. p. 128–44.
Google Scholar
Lejman M, Drabko K, Styka B, Winnicka D, Babicz M, Jaszczuk I, Kowalczyk JR. Usefulness of post-transplant hematopoietic chimera monitoring by use of the quantitative fluorescence polymerase chain reaction method. Transplant Proc. 2017. PMID: 28923646;49:1903–10. https://doi.org/10.1016/j.transproceed.2017.04.013.
Article
CAS
PubMed
Google Scholar
Lion T, Watzinger F, Preuner S, Kreyenberg H, Tilanus M, de Weger R, Lion T, Watzinger F, Preuner S, Kreyenberg H, Tilanus M, de Weger R, et al. The EuroChimerism concept for a standardized approach to chimeras analysis after allogeneic stem cell transplantation. Leukemia. 2012;26:1821–8. https://doi.org/10.1038/leu.2012.66.
Article
CAS
PubMed
Google Scholar
Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P, et al. Increasing mixed Chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic Leucemia after allogeneic stem cell transplantation: possible role for pre-Emptive immunotherapy? J Clin Oncol. 2004;22:1696–706.
Article
PubMed
Google Scholar
Qin XY, Li GX, Qin YZ, Wang Y, Wang FR, Liu DH, et al. Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49:1269–77. https://doi.org/10.1038/bmt.2014.158.
Article
CAS
PubMed
Google Scholar
Clark JR, Scott SD, Jack AL, Lee H, Mason J, Carter GI, et al. Monitoring of chimeras following allogeneic haematopoietic stem cell transplantation (HSCT): technical recommendations for the use of short tandem repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for leucocyte Immunophenotyping Chimerism working group. Br J Haematol. 2015;168:26–37. https://doi.org/10.1111/bjh.13073.
Article
PubMed
Google Scholar
Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R, et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant. 1998;21:487–95. https://doi.org/10.1038/sj.bmt.1701119.
Article
CAS
PubMed
Google Scholar
Preuner S, Peters C, Pötschger U, Daxberger H, Fritsch G, Gryeregger R, et al. Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia. Haematologica. 2016;101:741–6. https://doi.org/10.3324/haematol.2015.135137.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barrios M, Jimenez-Velasco A, Roman-Gomez J, Madrigal ME, Castillejo JA, Torres A, et al. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica. 2003;88:801–10.
PubMed
Google Scholar
Jiang Y, Wan L, Qin Y, Yan X, Xie K, Wang C. Donor Chimerism of B Cells and Natural Killer Cells Provides Useful Information to predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One. 2015;10(7):1–10. https://doi.org/10.1371/journal.pone.0133671.
Article
CAS
Google Scholar
Pachon C, Oger E, Michel G, Dalle JH, Salmon A, Nalken B, et al. Follow-up of post -transplanta minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react. Br J Haematol. 2015;169:249–61. https://doi.org/10.1111/bjh.13272.
Article
CAS
Google Scholar
Levrat E, Roosnek E, Masouridi S, Mohty B, Ansari M, Villard J, et al. Very long term stability of mixed Chimerism after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. Bone Marrow Res. 2015. https://doi.org/10.1155/2015/176526.
Article
Google Scholar
Lassaletta A, Ramirez M, Montero JM, et al. Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies. Bone Marrow Transplant. 2005;19:504–6. https://doi.org/10.1038/sj.leu.2403692.
Article
CAS
Google Scholar
Chen CT, Gau JP, Liu JH, Chiou TJ, Hsiao LT, Liu YC. Early achievement of full donor chimerism after allogeneic hematopoietic stem cell transplantation predicts lower relapse risk in patients with acute lymphoblastic leukemia. J Chin Med Assoc. 2018;81:1038–43. https://doi.org/10.1016/j.jcma.2018.06.005.
Article
PubMed
Google Scholar
Faraci M, Bognasco F, Leoni M, Giardino S, Terranova P, Subissi L, Di Duca M, Di Martino D, Lanino E. Evaluation of chimerism dynamics after allogeneic hematopoietic stem cell transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant. 2018;24:1088–102. https://doi.org/10.1016/j.bbmt.2017.12.801.
Article
PubMed
Google Scholar
Sakellarii I, Batsis I, Bousiou Z, Mallouri D, Constantinou V, Gavriilaki E, et al. The role of low-dose anti-thymocyte globulin as standard prophylaxis in mismatched and matched unrelated hematopoietic peripheral stem cell transplantation for hematologic malignancies. Clin Lymphoma Myeloma Leuk. 2017;17:658–66. https://doi.org/10.1016/j.clml2017.06.008.
Article
Google Scholar
Mossallam G, Kamel AM, Storer B, Martin PJ. Prognostic utility of routine Chimerism testing at 2-6 months after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15:352–9.
Article
PubMed
PubMed Central
Google Scholar
Doney KC, Loken MR, Bryant EM, et al. Lack of utility of chimerism studies obtained 2–3 months after myeloablative hematopoietic cell transplantation for ALL. Bone Marrow Transplant. 2008;42:271–4.
Article
PubMed
PubMed Central
Google Scholar
Jaksch M, Uzunel M, Remberger M, Sundberg B, Mattsson J. Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV. Clin Transpl. 2005;19:346–9. https://doi.org/10.1111/j.1399-0012.2005.00345.x.
Article
Google Scholar
Horn B, Wahlstrom JT, Melton A, Liou A, Ouachee-Chardin M, Sunkersett G, et al. Early mixed chimerism-based preemptive immunotherapy in children undergoing allogeneic hematopoietic stem cell transplantation for acute leukemia. Pediatr Blood Cancer. 2017;64:1–5. https://doi.org/10.1002/pbc.26464.
Article
CAS
Google Scholar
Rettinger E, Merker M, Salzmann-Manrique E, Kreyenberg H, Krenn T, Dürken M, et al. Pre-Emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation. Biol Blood Marrow Transplant. 2017;23:87–95. https://doi.org/10.1016/j.bbmt.2016.10.006.
Article
PubMed
Google Scholar